Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Geron Corporation

< Previous 1 2 3 4 Next >
Geron Reports Oral Presentation at ASH Annual Meeting Highlighting Continuous Long-Term Transfusion Independence with Imetelstat Treatment in Lower Risk MDS Patients
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Participate in Stifel 2022 Healthcare Conference
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Announces Presentations at Upcoming ASH Annual Meeting Including Long-term Phase 2 Data Showing Continuous Durable Transfusion Independence in Patients with Lower Risk MDS
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Reports Third Quarter 2022 Financial Results and Upcoming Expected Milestones
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Announce Third Quarter 2022 Financial Results on November 3, 2022
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Present at Upcoming Investor Conferences
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Reports Second Quarter 2022 Financial Results
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Announces Expansion of Existing Loan Facility
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Announces Appointment of Faye Feller, M.D. to Chief Medical Officer and Transition of Aleksandra Rizo, M.D., Ph.D. to Senior Advisor Role
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Present at the H.C. Wainwright Global Investment Conference
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Reports First Quarter 2022 Financial Results
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Announce First Quarter 2022 Financial Results on May 9, 2022
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Present at the 21st Annual Needham Virtual Healthcare Conference
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants
From Geron Corporation
Via Business Wire
Tickers GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Tickers GERN
Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference
From Geron Corporation
Via Business Wire
Tickers GERN
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.